Idcrp staph vaccine study

Ended Definitive Contract Awarded Last action

Contract number
W81XWH16C0125
Awardee
Awarding agency
Obligated
$3,735,479

Award facts

Contract value 100% obligated
$3,735,479.26 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Basic Research
Pricing
Firm Fixed Price
Place of performance
Grand Forks, ND 58202, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00004 -$23,485
Supplemental Agreement for work within scope P00003 $589,200
Supplemental Agreement for work within scope P00002 $0
Other Administrative Action P00001 $0
Original award $3,169,764

About this award

This is a $3,735,479.26 firm fixed price definitive contract awarded by the U.S. Army Medical Command (MEDCOM) to Novadigm Therapeutics, Inc. for an Infectious Disease Clinical Research Program (IDCRP) study on a Staphylococcus vaccine. The contract has a period of performance ending on January 31, 2020 and was awarded on September 16, 2016. The place of performance is Grand Forks, North Dakota. Novadigm Therapeutics, Inc. is a for-profit organization and the prime contractor for this award. This contract does not have a set-aside designation.

Quick answers

Who was awarded contract W81XWH16C0125?

W81XWH16C0125 was awarded to Novadigm Therapeutics, Inc. by Medical Command (Department of the Army) on September 16, 2016.

How much is contract W81XWH16C0125 worth?

The government has obligated $3,735,479 on W81XWH16C0125.

Was contract W81XWH16C0125 competed?

The extent of competition for W81XWH16C0125 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award